Canadian cannabis extractors given authorization to extract weed in Uganda

Pinterest LinkedIn Tumblr +

EXMceuticals Inc., a cultivator, and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutically and cosmetic industries have announced that it has received its formal full authorizations and permits for its Uganda operations.


This allows for the large-scale cultivation of cannabis, the extraction of cannabis ingredients and the export of the extracts.

The new license in Uganda enables EXM to cultivate cannabis and extract pharmaceutical, therapeutical and nutraceutical grade cannabis ingredients, including CBD, in-country.

Cultivation will begin immediately. Initial planting will consist of 100 hectares.

Cultivation and production facilities totaling 2,000 hectares (4,940 acres) of agricultural land available to plant and 2,000 sq. m. (21,500 sq. ft.) of lab, extraction, and material handling facilities.

The Ugandan extraction facilities to produce CBD oil have already been built, commissioned and inspected by the relevant Ugandan regulatory authorities.

After further refinement in the EXM facilities currently being established in Portugal, CBD and other cannabis isolates extracted from the cannabis grown in Uganda will be available to be distributed worldwide.

Brings EXM’s total cultivatable licensed land to over 84,000 hectares (207,500 acres) across multiple jurisdictions where CBD and other cannabis ingredients produced under the licenses can be cultivated and extracted.

The license also allows for the importation of high-quality cannabis seeds developed in Europe

Through its local subsidiary, Prime Ranchers Limited, EXM will now be able to cultivate and process cannabis in Uganda at an industrial scale. The Ugandan facilities will produce and export pharmaceutical, therapeutical, nutraceutical, and cosmetic grade cannabis ingredients.

The company says, within 90 days, it will be able to supply Ugandan produced cannabis extracted ingredients to any pharmaceutical, therapeutical, nutraceutical or cosmetic company which is duly licensed by the proper regulatory authorities in the countries in which they themselves operate.

The new license also enables the subsidiary to import high-quality cannabis seeds which have been developed in Europe in order to provide the seed-stock for the cultivation operations.

The entire land area of the project consists of over 2,000 hectares (4,940 acres), parcels of which will be put into production sequentially. Initial planting will consist of 100 hectares (247 acres) and the first plant harvest will occur within 4 months. All the relevant utilities such as power generation, water, and waste management, which are required by the first phase of the Project, are fully budgeted, funded and planned by the Company.